Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Imagin Medical Inc. (OTC: IMEXF).

Full DD Report for IMEXF

You must become a subscriber to view this report.


Recent News from (OTC: IMEXF)

Imagin Medical reports Q3 results
Imagin Medical ( OTCQB:IMEXF ): Q3 EPS of -$0.02 More news on: Imagin Medical Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: August, 14 2018 08:10
Imagin Medical Reports Fiscal 2018 Third Quarter Results
VANCOUVER, B.C. and BOSTON, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) today reported financial results for the three months ended June 30, 2018.  All amounts, unless...
Source: GlobeNewswire
Date: August, 14 2018 08:00
Imagin Medical Announces Stock Options Granted
VANCOUVER, B.C. and BOSTON, July 25, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) (the “Company”) announced today that, pursuant to the Company’s Stock Option Plan, an aggregate of 500,000 shares have been grant...
Source: GlobeNewswire
Date: July, 25 2018 08:30
Imagin Medical Reports Research Study Progress
VANCOUVER, British Columbia and BOSTON, July 17, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) announced today favorable results in the 10-subject investigator-sponsored research stud...
Source: GlobeNewswire
Date: July, 17 2018 16:30
Imagin Medical Announces Uplisting to OTCQB
VANCOUVER, British Columbia and BOSTON, June 27, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) is pleased to announce that its common shares were approved for uplisting from the Pi...
Source: GlobeNewswire
Date: June, 27 2018 16:30
Imagin Provides Further Detail on Kilmer Lucas Engagement
VANCOUVER, British Columbia and BOSTON, June 22, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) is pleased to provide, in addition to its press release of June 21, 2018, further det...
Source: GlobeNewswire
Date: June, 22 2018 16:05
Imagin Engages Kilmer Lucas for Cross-Border Investor Relations
VANCOUVER, British Columbia and BOSTON, June 21, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) today announced that it has engaged Kilmer Lucas Inc. ("Kilmer Lucas") to provide the...
Source: GlobeNewswire
Date: June, 21 2018 08:30
Imagin Gains Momentum; Positive Progress in Research Study
VANCOUVER, British Columbia and BOSTON, April 26, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) (the “Company”) is providing the following update on the Company’s current activities. The recent closing of a...
Source: GlobeNewswire
Date: April, 26 2018 08:30
Imagin Medical Closes Oversubscribed Private Placement
VANCOUVER, British Columbia and BOSTON, April 19, 2018 (GLOBE NEWSWIRE) -- Imagin Medical, Inc. (CSE:IME) (OTC PINK:IMEXF) (Frankfurt/Stuttgart Stock Exchanges:DPD2) (the “Company”) announces that, further to its press releases of April 3 and April 12, 2018, the Company is clo...
Source: GlobeNewswire
Date: April, 19 2018 08:30
Imagin Medical Selected as Featured Company in Video by InvestmentPitch Media - Video Available on InvestmentPitch.com
Vancouver, British Columbia--(Newsfile Corp. - April 17, 2018) - Imagin Medical (CSE: IME) (OTCPink: IMEXF) (FSE: DPD2), a medical imaging company with advanced optic and light sensor technology that will dramatically improve physicians' ability to visualize and detect cancer where endoscopes ...
Source: Newsfile
Date: April, 17 2018 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-180.1044850.100.1095910.098846,306
2018-12-170.09040.10210.10780.087871,129
2018-12-140.0710.1016850.10470.071154,892
2018-12-130.08850.07330.08850.073218,202
2018-12-120.0730.079920.0840.07366,160

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-173,00071,1294.2177Cover
2018-12-1443,633154,89228.1700Cover
2018-12-137,80018,20242.8524Short
2018-12-1216,36066,16024.7279Cover
2018-12-11138,750172,86580.2649Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on IMEXF.


About Imagin Medical Inc. (OTC: IMEXF)

Logo for Imagin Medical Inc. (OTC: IMEXF)

Imagin Medical is developing imaging solutions that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive surgery. The i/Blue Imaging System integrates advanced optics, state of the art, high resolution cameras and patented, image blending technology to produce images X more sensitive than currently available in less than a quarter of the time of conventional systems. Imagin s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than recurrence rate.

 

Contact Information

 

 

Current Management

  • E. James Hutchens / President
    • Jim Hutchens is a proven entrepreneur with over years of experience in general and marketing management in the medical technology industry. Mr. Hutchens served as a Managing Partner in Origin Partners, a million early stage, venture capital fund and was the founder and CEO of both Microsurge Inc., a venturebacked, minimally invasive surgery company, and Choice Therapeutics, an advanced woundcare company which was sold to Alliqua Biomedical a NASDAQ list company. Mr. Hutchens also served in senior executive positions at Microvasive Endoscopy, a division of Boston Scientific, Smith amp Nephew, and Millipore. He is a former member of the Board of Directors of the Brigham and Womens/ Faulkner Hospital and holds a BS in Business Administration from Boston University.
  • Sheila Boyle / Marketing Officer

Current Share Structure

  • Market Cap: $16,246,229 - 03/14/2018
  • Issue and Outstanding: 78,865,190 - 01/23/2017

 



Daily Technical Chart for (OTC: IMEXF)

Daily Technical Chart for (OTC: IMEXF)


Stay tuned for daily updates and more on (OTC: IMEXF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: IMEXF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in IMEXF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of IMEXF and does not buy, sell, or trade any shares of IMEXF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/